Genome editing technologies: Defining a path to clinic

Jacqueline Corrigan-Curay; Marina O'Reilly; Donald B. Kohn; Paula M. Cannon; Gang Bao; Frederic D. Bushman; Dana Carroll; Toni Cathomen; J. Keith Joung; David Roth; Michel Sadelain; Andrew M. Scharenberg; Christof Von Kalle; Feng Zhang; Robert Jambou; Eugene Rosenthal; Morad Hassani; Aparna Singh; Matthew H. Porteus

Conference ProceedingsOPEN ACCESS

Genome editing technologies: Defining a path to clinic

Molecular Therapy (2015) 23(5) 796-806

DOI: 10.1038/mt.2015.54

96Citations

175Readers

Get full text

Cite

CITATION STYLE

APA

Corrigan-Curay, J., O’Reilly, M., Kohn, D. B., Cannon, P. M., Bao, G., Bushman, F. D., … Porteus, M. H. (2015). Genome editing technologies: Defining a path to clinic. In Molecular Therapy (Vol. 23, pp. 796–806). Nature Publishing Group. https://doi.org/10.1038/mt.2015.54

Genome editing technologies: Defining a path to clinic

Cite

Register to see more suggestions